New DNA Test Detects Familial Hypercholesterolaemia

 
October 31, 2008

Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disease.

More like this

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Related News

Simple Home Test Can Halve the Risk of Stroke for Patients on Warfarin

April 29, 2013 — A simple self-monitoring test could reduce the risk of stroke by half in thousands of people in the...

Nanomix Initiates Clinical Testing of Point of Care In-Vitro Diagnostic (IVD) Cardiac Panel

April 15, 2013 —  Nanomix Inc. has initiated clinical testing in the United States to evaluate the Omega-3 Cardiac Panel.  The panel quantitatively tests...

Handheld ECG Helps Physicians Identify Risks for Sudden Cardiac Arrest in Young Athletes

February 27, 2013 — Cardea Associates announced the launch of its new electrocardiographic (ECG) device, CardeaScreen....

View all

Related Articles

Advances in Point-of-Care Anticoagulation Testing Systems

Anticoagulants, primarily warfarin, are used to prevent thrombosis and thromboembolism in patients with atrial fibrillation, artificial heart valves, deep venous thrombosis (DVT) and ...

Pocket Ultrasound Improves Care With Immediate Imaging

In the same fashion that the echocardiogram helped transform the cardiac exam, recent developments in the field of portable ultrasound are providing cardiologists with a new way to visualize the...

View all